Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

Juliet E. Bryant, Andrew S. Azman, Matthew J. Ferrari, Benjamin F. Arnold, Maciej F. Boni, Yap Boum, Kyla Hayford, Francisco J. Luquero, Michael J. Mina, Isabel Rodriguez-Barraquer, Joseph T. Wu, Djibril Wade, Guy Vernet, Daniel T. Leung

Research output: Contribution to journalArticle

Abstract

Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level).

Original languageEnglish (US)
JournalScience Immunology
Volume5
Issue number47
DOIs
StatePublished - May 19 2020

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward'. Together they form a unique fingerprint.

  • Cite this

    Bryant, J. E., Azman, A. S., Ferrari, M. J., Arnold, B. F., Boni, M. F., Boum, Y., Hayford, K., Luquero, F. J., Mina, M. J., Rodriguez-Barraquer, I., Wu, J. T., Wade, D., Vernet, G., & Leung, D. T. (2020). Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward. Science Immunology, 5(47). https://doi.org/10.1126/sciimmunol.abc6347